DK0981349T3 - 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme - Google Patents

5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme

Info

Publication number
DK0981349T3
DK0981349T3 DK98918789T DK98918789T DK0981349T3 DK 0981349 T3 DK0981349 T3 DK 0981349T3 DK 98918789 T DK98918789 T DK 98918789T DK 98918789 T DK98918789 T DK 98918789T DK 0981349 T3 DK0981349 T3 DK 0981349T3
Authority
DK
Denmark
Prior art keywords
pregnan
tumors
beta
alpha
sulfate
Prior art date
Application number
DK98918789T
Other languages
Danish (da)
English (en)
Inventor
Michael Z Kagan
Syed Muzafar Shah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0981349T3 publication Critical patent/DK0981349T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK98918789T 1997-05-02 1998-04-28 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme DK0981349T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85056797A 1997-05-02 1997-05-02
PCT/US1998/008456 WO1998050042A1 (en) 1997-05-02 1998-04-28 Pregnan-3-ol-20-ones

Publications (1)

Publication Number Publication Date
DK0981349T3 true DK0981349T3 (da) 2003-03-10

Family

ID=25308504

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98918789T DK0981349T3 (da) 1997-05-02 1998-04-28 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme

Country Status (15)

Country Link
EP (1) EP0981349B1 (es)
JP (1) JP2001525807A (es)
KR (1) KR20010012157A (es)
CN (1) CN1254283A (es)
AR (1) AR012638A1 (es)
AT (1) ATE227130T1 (es)
AU (1) AU739146B2 (es)
BR (1) BR9809376A (es)
CA (1) CA2289006A1 (es)
DE (1) DE69809223T2 (es)
DK (1) DK0981349T3 (es)
ES (1) ES2186153T3 (es)
PT (1) PT981349E (es)
WO (1) WO1998050042A1 (es)
ZA (1) ZA983705B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69927960T2 (de) * 1998-03-11 2006-07-20 Torbjörn Backström Epiallopregnanolon zur behandlung von krankheiten des cns
SE0104423D0 (sv) 2001-12-27 2001-12-27 Umecrine Ab Pregnane steroids and their use in the treatment of CNS disorders
US7572780B2 (en) * 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
US7473687B2 (en) 2005-03-24 2009-01-06 Emory University Methods for the treatment of a traumatic central nervous system injury
CA2601715C (en) 2005-03-24 2012-10-16 Emory University Dosage regimen for the treatment of a traumatic brain injury with progesterone
WO2006117592A1 (en) * 2005-04-29 2006-11-09 Inserm Methods of modulating nuclear receptors
EP2523666B8 (en) * 2010-01-14 2016-04-06 Asarina Pharma AB A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties

Also Published As

Publication number Publication date
EP0981349B1 (en) 2002-11-06
EP0981349A1 (en) 2000-03-01
ATE227130T1 (de) 2002-11-15
DE69809223D1 (de) 2002-12-12
CN1254283A (zh) 2000-05-24
AU739146B2 (en) 2001-10-04
AR012638A1 (es) 2000-11-08
AU7164798A (en) 1998-11-27
DE69809223T2 (de) 2003-07-24
CA2289006A1 (en) 1998-11-12
ES2186153T3 (es) 2003-05-01
JP2001525807A (ja) 2001-12-11
ZA983705B (en) 1999-11-01
PT981349E (pt) 2003-01-31
BR9809376A (pt) 2000-07-04
KR20010012157A (ko) 2001-02-15
WO1998050042A1 (en) 1998-11-12

Similar Documents

Publication Publication Date Title
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
DK1003479T3 (da) Fremgangsmåde og sammensætninger til behandling af allergiske senfasereaktioner og inflammatoriske sygdomme
DK1083889T3 (da) Tetrahydronaphthalenforbindelser og deres anvendelse til behandling af neurodegenerative sygdomme
DK0781136T3 (da) Forbindelser og fremgangsmåder til behandling af cancer
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
DK0830864T3 (da) Kombinationsbehandling til behandling af psykoser
DK0971735T3 (da) Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom
DK2305282T3 (da) Forebyggelse og behandling af amyloidogen sygdom
ID27841A (id) Turunan-turunan biaril terapeutik
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1094733T3 (da) Fremgangsmåde til fremstilling af børstehårsvarer og børstehårsvarer fremstillet herefter
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
DK0752870T3 (da) Anvendelse af Mycobacterium til behandling af tumorer
DK0831098T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af olanzapin
IS5056A (is) Ný meðhöndlun á liðbólgu
DK21795A (da) Fremgangsmåde til fremstilling og oprensning af ioderede kontrastmidler
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO994178D0 (no) Atropisomere av 3-heteroaryl-4(3H)-kinazoloner for behandling av neurodegenerative og CNS-trauma-relaterte tilstander
DK0981349T3 (da) 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO20002873D0 (no) FremgangsmÕte for økning av produksjonen og forbedring av kvaliteten til sæd
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser